Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1980-12-22
1982-03-16
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
043201180
ABSTRACT:
Novel peptides of the formula: ##STR1## wherein: A, A' and A" are each independently Gly, D-Ala, D-Leu, or D-Trp, wherein A may optionally be N-alkylated or N-acylated;
REFERENCES:
patent: 4046877 (1977-09-01), White et al.
Gonzalez et al., Biochem J., 1971, 309-317.
Kustu et al., The J. of Biological Chem., 249, 6976-6983 (1974).
Burton Pamela M.
Jones Gordon H.
Nestor John J.
White, deceased Abraham
Krubiner Alan M.
Moran Tom M.
Murashige Kate H.
Phillips Delbert R.
Syntex (U.S.A.) Inc.
LandOfFree
Deca-, undeca-, dodeca- and tridecapeptides with thymic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Deca-, undeca-, dodeca- and tridecapeptides with thymic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deca-, undeca-, dodeca- and tridecapeptides with thymic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1641742